Payer and HTA submissions: how digital technology is transforming market access processes

March 30, 2020

In the first of her five-part series on digital transformation in market access, Dr Patti Peeples, CEO of, sits down with Claire Chadwick, HTA Manager at PRMA Consulting, to learn about the technology that is helping market access professionals navigate the evolving challenges of HTA and payer submissions.

Dr. Peeples: What challenges do pharmaceutical and biotechnology market access professionals face when developing HTA and payer submissions?

Claire Chadwick: Successfully navigating HTA and payer submissions to achieve favorable pricing and access across multiple products and indications at the same time is a complex process. It is can be associated with significant business risk and potential delays to patient access.

I commonly work with manufacturers that are faced with the challenges of:

  • constructing strong value arguments that meet evolving payer requirements
  • giving affiliates’ support to manage their limited time and resources
  • providing effective materials to ensure that global strategy is incorporated into local submissions.

Digital transformation is helping those market access professionals improve the quality of their submissions, drive efficiency in their processes, and enhance collaboration between international and local teams.

It’s an exciting time for everyone in the industry.

Dr. Peeples: How can digital technology help market access professionals meet payer requirements? 

Claire Chadwick: HTA and payer submission templates and guidance documents are always evolving and need to be monitored and updated as requirements change. The challenge is even greater where official templates do not exist.

New technology makes it easier for multiple users to stay up to date with changing agency and payer needs.

Our own digital application, the PRMA Navigator®, is a good example. In the application you will find the most recent templates for the US, Canada, Australia, and multiple European markets. Because it’s a cloud-based application we can rapidly share new templates and expert advice on key supporting evidence.

Our free eBook explains more about how the technology has revolutionized how clients are understanding and meeting payer and HTA requirements.

Dr. Peeples: You mentioned better support of affiliates. How have you seen digital technology help organizations meet that need?

Claire Chadwick: I’m seeing increasing pressure on affiliate teams to balance their limited time and resources.

It’s common that they are splitting their time between:

  • understanding complex value stories and global evidence packages
  • generating local real-world data
  • engaging with an evolving stakeholder landscape
  • developing innovative pricing and contracting models

Digital technology is helping affiliates save time. The PRMA Navigator® gives users a head start through the delivery of auto-populated draft submissions that are up to 80% complete within as little as 2 weeks and are aligned with the global strategy for the product.

This gives them more time to develop the local evidence-based components of the HTA and payer submissions and engage with stakeholders to perfect the local strategic narrative.

Dr. Peeples: Many readers are tasked with populating multiple payer and HTA submissions. What are the most important things that they need to consider?

Claire Chadwick: It’s important that the latest supporting evidence is consistently disseminated across multiple draft submissions.

Supporting evidence should include content from a pre-approved package of global, regional, and local supporting documents, such as value dossiers, clinical study reports, economic model reports, local epidemiological reports, and treatment guidelines.

The evidence package needs to be agreed in collaboration with global and local teams.

The PRMA Navigator® meets these needs, where global knowledge transfer is key.

The auto-population feature of the PRMA Navigator® gives you:

  • confidence that at any given time the draft submissions are populated with the most up-to-date supporting evidence
  • strategic mapping of evidence to core and local payer requirements
  • the ability to easily input relevant content across each draft submission in the project’s scope

This gives you time back to focus on the most strategic sections of the submission.

Dr. Peeples:  Do you have any tips for improving the content of global value dossiers (GVDs)?

Claire Chadwick: Our experience is that robust global evidence packages lead to higher-quality and more cost-effective submissions. They support quicker product launches and higher price points, as well as minimizing value erosion for follow-on indications.

We recommend conducting a comprehensive gap analysis to identify payer and HTA requirement gaps in the GVD. This drives the development of more targeted and affiliate-focused global deliverables.

PRMA Consulting has developed a gold-standard GVD template that optimizes the structure and content of global source material, to support the efficient development of quality local submissions.

It has been structured with HTA templates and agency guidance from countries across the world in mind, and includes core content requirements that are consistent across current templates and agency guidance.

This captures the breadth of evidence necessary to meet the criteria of multiple agencies.

To download a free copy of the eBook “How to accelerate the generation of simultaneous, high-quality payer and HTA submissions, click the button below.

Share This Story!